Emily Bombard, | |
10 Drake Dr, Greenland, NH 03840-2112 | |
(603) 828-7089 | |
Not Available |
Full Name | Emily Bombard |
---|---|
Gender | Female |
Speciality | Registered Nurse - Lactation Consultant |
Location | 10 Drake Dr, Greenland, New Hampshire |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1992163265 | NPI | - | NPPES |
055979-21 | Other | NEW HAMPSHIRE BOARD OF NURSING | |
L-20911 | Other | IBLCE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163WL0100X | Registered Nurse - Lactation Consultant | 055979-21 (New Hampshire) | Primary |
Mailing Address | Practice Location Address |
---|---|
Emily Bombard, 10 Drake Dr, Greenland, NH 03840-2112 Ph: () - | Emily Bombard, 10 Drake Dr, Greenland, NH 03840-2112 Ph: (603) 828-7089 |
News Archive
Australia should do more to prevent diabetes and provide better care for those living with the disease, according to an author of the World Health Organisation's (WHO) first ever global diabetes report.
Scientists have revealed that an anti-obesity drug changes the way the brain responds to appetising, high-calorie foods in obese individuals. This insight may aid the development of new anti-obesity drugs which reduce the activity in the regions of the brain stimulated by the sight of tasty foods.
Less than one-third of COVID-19 clinical trials are led by women, which is half the proportion observed in non-COVID-19 trials, according to research led by Queen Mary University of London, University of St Andrews, Brigham and Women's Hospital and Harvard Medical School.
Hologic, Inc. (Hologic or the Company), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the jury in the patent infringement lawsuit against SenoRx brought by Hologic, Cytyc Corp., and Hologic L.P., Inc. in the U.S. District Court for the Northern District of California has returned a verdict in favor of SenoRx.
› Verified 4 days ago